Twinning-2024-header

WFH Twinning Program welcomes seven new partnerships

The World Federation of Hemophilia (WFH) Twinning Program funds short-term collaborative partnerships between medical professionals, patient organizations, and youth leaders from around the world. The Program promotes capacity building and sustainability through knowledge and expertise exchange between partners. In January 2024, the WFH welcomed seven new twinning partnerships from Angola-Brazil, Djibouti-Tunisia, the Gambia-U.S.A, Guyana-U.S.A, Malta-U.K., Mauritius-India, and Trinidad & Tobago-Canada.

Also available in: Français Español

The WFH Twinning Program has two main streams focusing on hemophilia patient organizations and hemophilia treatment centres. Hemophilia Organization Twinning (HOT) continues to make significant strides in supporting patient organizations worldwide. With a focus on organizational capacity-building and advocacy, HOT aims to improve services to patients and their families and effectively support people living with bleeding disorders. In 2024, two exciting new partnerships were approved to join HOT:

These twins have several key goals they have committed to achieving during the duration of their partnerships. They aim to develop effective governance structures, enhance advocacy skills and strategies, create sustainable financial policies, conduct impactful educational campaigns, and develop educational resources and communication tools for the bleeding disorder community.

We are highly enthusiastic about the potential partnership between Campinas and Luanda. We have tremendous confidence that this collaboration will be successful and will yield valuable results.

—Silmara Aparecida de Lima Montalvão, Laboratory Supervisor, International Hemophilia Training Centre (IHTC) Campinas

Hemophilia Treatment Centre (HTC) Twinning supports medical professionals so they can provide adequate care and treatment for people living with bleeding disorders. This year, the Program celebrates the approval of four new partnerships:

The goals of these new HTC Twinning partners include developing a multidisciplinary approach to the comprehensive management of bleeding disorders, advancing laboratory diagnosis, improving registries, increasing data collection, and providing therapeutic patient education.

Additionally, the youth component of the WFH Twinning Program plays a vital role in strengthening youth group membership and empowering young national member organization (NMO) members. The new 2024 Youth Twins—the Haemophilia Association of Mauritius and the Hemophilia Federation (India)—have as their goal developing a succession plan, strategically structuring their youth group, and fostering youth leadership and engagement.

The WFH looks forward to supporting these new partnerships and working together effectively to serve people living with bleeding disorders worldwide.

To find out more about the WFH Twinning Program, click here.

The WFH Twinning Program is supported by exclusive funding from Pfizer.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.